Even though research is always moving forward in search of news ways to diagnose, treat, and understand multiple sclerosis (MS), there are still a lot of questions with no answers. Especially important to patients is whether new medicines could be more effective for MS than those that are already developed and currently in use.
In an attempt to redefine and rediscover medicine and science, Genentech’s Group Medical Director Dr. Peter Chin, and his team have been developing clinical trials and monitoring the data they generate to determine the safety and efficacy of particular therapy candidates.
As a way to further understand multiple sclerosis Chin wrote an interesting article about the disease, how research has been evolving, and how MS can be measured. The article “Genentech: Measuring MS” explores the biology of MS, the symptoms that can vary from person to person, MS relapses, physical disability, biological markers, and other important information.
Click here to read Chin’s full article.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.